Hyun-Joon Ha
Chief Tech/Sci/R&D Officer chez DUCHEMBIO CO.,LTD.
Profil
Hyun-Joon Ha is the founder of Chembionex Co., Ltd.
(founded in 2000).
He is currently the Director & Chief Scientific Officer at IMAGENE Co., Ltd.
and the Head-Research Institute at DuChemBIO Co., Ltd.
Dr. Ha previously worked as a Professor at Hankuk University of Foreign Studies.
He holds a doctorate degree from Brown University (conferred in 2000) and has also studied at Stanford University and Seoul National University.
Postes actifs de Hyun-Joon Ha
| Sociétés | Poste | Début |
|---|---|---|
| DUCHEMBIO CO.,LTD. | Chief Tech/Sci/R&D Officer | - |
IMAGENE Co., Ltd.
 IMAGENE Co., Ltd. BiotechnologyHealth Technology IMAGENE Co., Ltd. researches and develops treatment for cancer and infectious diseases. Its products include antibody43, chiral building blocks, and aminoacyl-tRNA synthetase inhibitors. The company was founded on December 1, 1997 and is headquartered in Yongin, South Korea. | Chief Tech/Sci/R&D Officer | 16/06/2011 |
Anciens postes connus de Hyun-Joon Ha
| Sociétés | Poste | Fin |
|---|---|---|
| Hankuk University of Foreign Studies | Corporate Officer/Principal | - |
| Chembionex Co., Ltd. | Founder | - |
Formation de Hyun-Joon Ha
| Brown University | Doctorate Degree |
| Stanford University | Graduate Degree |
| Seoul National University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DUCHEMBIO CO.,LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
IMAGENE Co., Ltd.
IMAGENE Co., Ltd. BiotechnologyHealth Technology IMAGENE Co., Ltd. researches and develops treatment for cancer and infectious diseases. Its products include antibody43, chiral building blocks, and aminoacyl-tRNA synthetase inhibitors. The company was founded on December 1, 1997 and is headquartered in Yongin, South Korea. | Health Technology |
| Chembionex Co., Ltd. |
